Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review

Featuring an interview with Dr Terence Friedlander, including the following topics:

Perioperative durvalumab with neoadjuvant chemotherapy: Health-related quality-of-life outcomes in the NIAGARA trial (0:00)

Targeting HER2 in locally advanced or metastatic urothelial carcinoma (5:17)

TROP2-targeted antibody-drug conjugates for locally advanced or metastatic urothelial carcinoma (18:19)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.